Focus topics

Novartis focuses on China’s aging population

The head of Swiss pharmaceutical giant Novartis, Vasant Narasimhan, sees major growth opportunities in China despite its shrinking population. “If you look at the unmet need in China for the treatment of many chronic diseases, it is significant,” Narasimhan said.

Continue reading now

… and get free access to this Professional Briefing for a month.

Are you already a guest at the China.Table? Log in now


    New evidence for Covid animal origin theory
    Lula brings large delegation
    German Minister of Education and Research visits Taiwan
    Foreign ministers of China and Ukraine talk on the phone